Serono Labs
Executive Summary
Jules Musing to succeed Thomas Wiggins as president of U.S. drug business. Wiggins is transferring to a new position within the company in Europe. Musing presently is VP of acquisitions for the Ares-Serono Group, based in its Boston offices.